Category: Lymphoma

CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Optimizing HSCT in Blood Cancers

Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA

Key Insights from Attending ASH 2025

Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

CAR-T in 2025: Advancements and the Road Ahead

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX

Exploring Cutaneous T-Cell Lymphoma

Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL

Highlights from Attending ASH 2024

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Scroll to Top